Position in NTRA
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$40,717
+$20,519 QoQ
Shares Held
150
+48.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#707
of 844 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Raiffeisen Bank International AG holds $157,238,037 across 12 Diagnostics & Research names. NTRA ranks #10 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
138,757 | $69,567,209 | |
| 2 | DHR |
Danaher Corp /De/
|
162,772 | $31,004,810 | |
| 3 | MTD |
Mettler Toledo International Inc/
|
17,287 | $22,084,315 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
41,815 | $22,013,088 | |
| 5 | A |
Agilent Technologies, Inc.
|
73,572 | $9,772,568 | |
| 6 | CRL |
Charles River Laboratories International, Inc.
|
6,000 | $1,360,740 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
6,500 | $1,255,930 | |
| 8 | DGX |
Quest Diagnostics Inc
|
239 | $50,656 |
All Filings in NTRA
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $40,717 | 150 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $20,198 | 101 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $876,956 | 3,828 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $616,193 | 3,828 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $629,639 | 3,727 | Shares | Sole | 2025-08-11 | |
| No filing history on record for this holder in this stock. | ||||||